Skip to main content

Table 3 Univariate analyses for the assessment of all segments during the SLS, the total score

From: Factors associated with the Single Leg Squat test in female soccer players: a cross-sectional study

Variable

SLS test for all segments: non-dominant leg

SLS test for all segments: dominant leg

na

Cases (%) b

ORc

95% CId

p-valuee

na

Cases (%) b

ORc

95% CId

p-valuee

Division

254

117 (46)

1.43

1.08–1.89

0.01*

254

176 (69)

1.25

0.93–1.6

0.14

Div. 1

89

32 (36)

1

  

89

56 (63)

1

  

Div. 2

51

24 (47)

1.58

0.79–3.19

 

51

37 (73)

1.56

0.74–3.30

0.25

Div. 3

114

61 (54)

2.05

1.16–3.62

0.01*

114

83 (73)

1.58

0.87–2.86

0.13

Age category

254

115 (45)

0.65

0.47–0.91

0.01*

254

176 (69)

0.97

0.69–1.37

0.86

16–19 years

84

47 (56)

1

  

84

61 (73)

1

  

20–24 years

99

45 (46)

0.66

0.37–1.18

0.16

99

64 (65)

0.69

0.37–1.30

0.25

25–39 years

71

25 (35)

0.43

0.22–0.82

0.01*

71

51 (72)

0.96

0.48–1.95

0.91

Ankle dorsiflexionf

254

117 (46)

0.97

0.92–1.03

0.39

254

176 (69)

0.92

0.86–0.99

0.03*

Hip strengthg

253

117 (46)

0.99

0.98–0.99

0.04*

252

174 (69)

0.99

0.98–0.99

0.02*

A severe injuryh

247

114 (46)

   

247

170 (69)

   

No

195

100 (51)

1

  

190

130 (68)

1

  

Yes

52

14 (27)

0.35

0.18–0.69

0.00*

57

40 (70)

1.09

0.57–2.07

0.80

A time-loss injuryi

250

113 (45)

   

250

174 (70)

   

No

161

76 (47)

   

135

88 (65)

1

  

Yes

89

39 (44)

1

0.52–1.47

0.61

115

86 (75)

1.58

0.91–2.75

0.10

An injury problemj

254

117 (46)

0.87

  

254

176 (69

   

No

224

99 (44)

1

  

214

147 (69)

1

  

Yes

30

18 (60)

1.89

0.87–4.11

0.11

40

29 (73)

1.20

0.57–2.55

0.63

AFAQgk

252

115 (46)

0.97

0.93-1.00

0.07

252

174 (69)

0.99

0.96–1.03

0.72

PSS-14l

252

115 (46)

0.96

0.90–1.03

0.25

252

174 (69)

0.94

0.87–1.01

0.09

PSQIm

252

115 (46)

   

252

174 (69)

   

Good sleepers, ≤ 5 points

156

66 (42)

1

  

156

105 (68)

1

  

Poor sleepers, ≥ 6 points

96

49 (51)

1.42

0.85–2.37

0.18

96

69 (71)

1.24

0.71–2.17

0.45

GAD-7n

252

115 (46)

1.07

0.77–1.49

0.70

252

174 (69)

1.36

0.94–1.97

0.11

No anxiety

108

49 (45)

1

  

108

68 (63)

1

  

Mild anxiety ≥ 5 points

98

43 (44)

0.94

0.54–1.63

0.83

98

72 (74)

163

0.90–2.95

0.11

Moderate/severe anxiety ≥ 10 points

46

23 (50)

1.20

0.60–2.40

0.60

46

34 (74)

1.67

0.78–2.51

0.19

  1. *Denotes a statistically significant differences at p ≤ 0.05;
  2. an: total sample; bCases (%): total number of subjects failing on the SLS test, and in brackets, the risk/probability to fail the SLS test expressed in the percentage of the total number of performed Single Leg Squats; cOR: odds ratio; d95% CI: 95% confidence interval; ep-value: probability value; fAnkle dorsiflexion: measured with the Weight Bearing Dorsiflexion Lunge Test (WBLT) and calculated with a trigonometric dorsiflexion angle (TA); gHip strength: Side-Lying Clamshell (CLAM), body-sized independent measurement; Newton (N)*length of femur (m)/ (Body weight (kg)*height (m)) *100; hA severe Injury: One or more time-loss injuries located in the head, lower belly, lower back, pelvis or lower extremities, during season 2021 or earlier, that lasted three months or more; iA time-loss injury: One or more time-loss injuries located in the head, lower belly, lower back, pelvis or lower extremities during season 2021; jAn injury problem: An injury problem located in the head, lower belly, lower back, pelvis or lower extremities that did not demand any time-loss from game or training during the four weeks before or during the test occasion; kAFAQ: Athletic Fear Avoidance Questionnaire; lPSS-14: Perceived Stress Scale 14-item instrument; mPSQI: Pittsburgh Sleep Quality Index; nGAD-7: Generalized Anxiety Disorder 7-item scale